Expression of nitric oxide synthase isoforms and nitrotyrosine immunoreactivity by B-cell non-Hodgkin's lymphomas and multiple myeloma

Histopathology

Volumn 39, Issue 2, 2001, Pages 172-178

  Mendes, R V ^a   Martins, A R ^a   De Nucci, G ^a   Murad, F ^b   Soares, F A ^c,d  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c A C CAMARGO CANCER CENTER   (Brazil)

^d São Paulo ^*  (Brazil)

Author keywords

B lymphocytes; Human B cell neoplasms; Immunohistochemistry; Multiple myeloma; Nitric oxide; Nitric oxide synthase; Nitrotyrosine; Non Hodgkin's lymphoma

Indexed keywords

3 NITROTYROSINE; ISOENZYME; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; ENZYME ASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ASSAY; TUMOR CELL;

ADULT; AGED; CELL NUCLEUS; CYTOPLASM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; LYMPHOMA, B-CELL; MALE; MIDDLE AGED; MULTIPLE MYELOMA; NITRIC OXIDE SYNTHASE; TYROSINE;

EID: 0035571229     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.2001.01189.x     Document Type: Article

References (29)

1. Isoforms of nitric oxide synthase. Properties, cellular distribution and expressional control
2. Expressional control of the 'constitutive' isoforms of nitric oxide synthase (NOS I and NOS III)
3. Inducible nitric oxide synthase in human diseases
4. Nitric oxide, the biological mediator of the decade: Fact or fiction?
5. Nitric oxide
6. Chemical biology of nitric oxide, insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide
7. Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation
8. Nitric oxide synthase activity in human gynecological cancer
9. Nitric oxide activity in human breast cancer
10. Nitric oxide activity and expression in human colorectal cancer
11. Frequent nitric oxide synthase-2 expression in human colon adenomas: Implication for tumor angiogenesis and colon cancer progression
12. Expression of nitric oxide synthase in human central nervous system tumors
13. Immunohistochemical characterization of nitric oxide synthase activity in squamous cell carcinoma of the head and neck
14. Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer
15. The multifaceted roles of nitric oxide in cancer
16. Nitric oxide involvement in tumor-induced immunosuppression
17. Apoptotic death of human leukemic cells induced by vascular cells expressing nitric oxide synthase in response to γ-interferon and tumor necrosis factor-α
18. B-cell chronic lymphocytic leukemia cells express a functional inducible nitric oxide synthase displaying anti-apoptotic activity
19. Expression of human inducible nitric oxide synthase in T-cell lines infected with human T-cell leukaemia virus type-I and primary adult T-cell leukaemia cells
20. A revised European-American classification of lymphoid neoplasms: A proposal from the international lymphoma study group
21. Pharmacological and immunohistochemical evidence for a functional nitric oxide synthase system in rat peritoneal eosinophils
22. Nitrotyrosine formation with endotoxin-induced kidney injury detected by immunohistochemistry
23. Microwave-stimulated recovery of myosin-V immunoreactivity from formalin-fixed, paraffin-embedded human CNS
24. Nitric oxide production in relation to spontaneous B-cell lymphoma and myositis in SJL mice
25. Biological tyrosine nitration: A pathophysiological function of nitric oxide and reactive oxygen species
26. Peroxynitrite inhibits T lymphocyte activation and proliferation by promoting impairment of tyrosine phosphorylation and peroxynitrite-driven apoptotic death
27. Expression of differential nitric oxide synthase in human normal gastric mucosa and gastric cancer tissue
28. Tumor cell nitric oxide inhibits cell growth in vitro, but stimulates tumorigenesis and experimental lung metastasis in vivo
29. Splenic B lymphocyte programmed cell death is prevented by nitric oxide released through mechanisms involving sustained Bcl-2 levels